Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Benefits and bottlenecks for early marketing authorisation of new medicines Patients are asking increasingly often for quicker access to new, innovative medicines. This requires a more effective use of flexible marketing authorisation procedures.
European Baseline Report SUSTAIN The SUSTAIN project has published the European baseline report titled ‘Integrated care for older people living at home – Current situation and ambition of sites participating in the SUSTAIN project
Particle contamination on Silimed breast implants poses minimal risk Particles were found on Silimed silicone-based breast implants that should not be there. These included man-made mineral fibres, such as glasswool and rockwool.
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.
RIVM research basis for historic climate agreement on HFCs Scientific research by RIVM’s Guus Velders stood partly at the basis of the HFC global climate agreement.
Documentary Sea Blind on Dutch Television Sea Blind is a documentary about the impact of shipping on the environment, especially on the Arctic Sea.
Shortcomings in technical documentation of both existing and new blood glucose meters RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.